Christoph Groth

Severe deficiency of switched memory B cells (CD27+IgM−IgD−) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease

Klaus Warnatz, Axel Denz, Ruth Dräger et al. · Blood · 2002 · 626 citations

Life Sciences, Hematology, Immunology +15

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

Roy F. Chemaly, Andrew J. Ullmann, Susanne Stoelben et al. · New England Journal of Medicine · 2014 · 371 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

Uwe Platzbecker, Jan Moritz Middeke, Katja Sockel et al. · The Lancet Oncology · 2018 · 354 citations

Medicine, Hematology, Pharmacology +17

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes et al. · The Lancet Haematology · 2019 · 154 citations · Full text

Medicine, Hematology, Immunology +17

PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation

J C Albring, Sabrina Inselmann, Tim Sauer et al. · Bone Marrow Transplantation · 2016 · 82 citations

Medicine, Immunology, Oncology +16